Chesnara Plc: Acquisitions show immediate benefits
2 September 2026
Alvotech (NASDAQ: ALVO), a notable player in the healthcare sector specializing in biosimilar drug manufacturing, has caught the attention of investors with its substantial growth prospects. With a market capitalization..
Metsera, Inc. (NASDAQ: MTSR), a burgeoning player in the biotechnology sector, is capturing investor attention with a striking potential upside of 93.32%, according to analyst assessments. This clinical-stage company, headquartered..
DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a stalwart in the healthcare sector specializing in medical instruments and supplies, presents an intriguing opportunity for investors seeking exposure to the dental equipment market...
Cytokinetics, Incorporated (NASDAQ: CYTK) is garnering significant attention in the biotechnology sector, not only for its innovative drug development pipeline but also for its compelling potential upside in the stock..
TG Therapeutics, Inc. (NASDAQ: TGTX), a prominent player in the biotechnology sector, has been capturing investor attention with its remarkable 90.4% revenue growth. Specializing in the development and commercialization of..
TransMedics Group, Inc. (TMDX), a pioneering force in the healthcare sector, is making waves with its innovative approach to organ transplant therapy. As a commercial-stage medical technology company, TransMedics specializes..
Legend Biotech Corporation (NASDAQ: LEGN), a prominent player in the healthcare sector specializing in biotechnology, is capturing investor attention with its innovative approach to cancer treatment. With a market capitalization..
Grifols, S.A. (NASDAQ: GRFS) stands out in the healthcare sector with its robust portfolio in the plasma therapeutics market. With a market capitalization of $7.39 billion, this Spanish pharmaceutical giant..
HealthEquity, Inc. (NASDAQ: HQY), a leader in the healthcare information services sector, is capturing the interest of investors with its promising outlook. Based in Draper, Utah, HealthEquity offers a range..
For investors seeking opportunities in the biotech sector, Soleno Therapeutics, Inc. (NASDAQ: SLNO) offers a compelling proposition. Headquartered in Redwood City, California, Soleno is a clinical-stage biopharmaceutical company that specializes..
Akero Therapeutics, Inc. (NASDAQ: AKRO) is making waves in the biotechnology sector with its pioneering approach to tackling metabolic diseases, notably through its lead candidate, efruxifermin (EFX). Headquartered in South..
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) has captured the attention of the investment community with its promising pipeline in the biotechnology sector, targeting rare genetic disorders. Despite a challenging market environment,..
Moderna, Inc. (NASDAQ: MRNA), a prominent player in the biotechnology sector, has been on the radar of investors and analysts alike, given its significant role in developing mRNA-based medicines. As..
Halozyme Therapeutics, Inc. (NASDAQ: HALO) stands out in the competitive biotechnology sector, offering a compelling investment narrative with its innovative approach to drug delivery and a promising 28.33% potential upside..
Henry Schein, Inc. (HSIC), a prominent player in the healthcare sector, is a leading distributor of healthcare products and services, primarily catering to office-based dental and medical practitioners across the..
Oscar Health, Inc. (NYSE: OSCR), a pioneering healthcare technology firm, is making waves in the healthcare plans sector with its robust revenue growth. Investors are keenly evaluating the company’s trajectory..
Bausch + Lomb Corporation (BLCO), a prominent player in the healthcare sector, is renowned for its strong presence in the medical instruments and supplies industry. With a global footprint spanning..
Universal Health Services, Inc. (NYSE: UHS), a prominent player in the healthcare sector, stands as a compelling investment opportunity with a market capitalization of $11.48 billion. Based in King of..
Avidity Biosciences, Inc. (NASDAQ: RNA) is capturing the attention of investors with a potential upside of 131.61%, making it a compelling candidate in the biotechnology sector. Headquartered in San Diego,..
Krystal Biotech, Inc. (NASDAQ: KRYS), a cutting-edge player in the biotechnology sector, is capturing investor attention with its impressive trajectory in genetic medicines. Based in Pittsburgh, Pennsylvania, the company focuses..
